BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 27166258)

  • 1. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
    Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
    Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p.
    Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J
    Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
    Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
    Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-153/Nrf-2/GPx1 pathway regulates radiosensitivity and stemness of glioma stem cells via reactive oxygen species.
    Yang W; Shen Y; Wei J; Liu F
    Oncotarget; 2015 Sep; 6(26):22006-27. PubMed ID: 26124081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5.
    Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J
    Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.
    Song H; Zhang Y; Liu N; Zhao S; Kong Y; Yuan L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.
    Yang W; Liu Y; Gao R; Yu H; Sun T
    Cancer Lett; 2018 Feb; 415():164-176. PubMed ID: 29222038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
    Su R; Cao S; Ma J; Liu Y; Liu X; Zheng J; Chen J; Liu L; Cai H; Li Z; Zhao L; He Q; Xue Y
    Mol Cancer; 2017 Nov; 16(1):171. PubMed ID: 29132362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of long non-coding RNA PCAT1 in glioma stem cells promotes radiation sensitivity.
    Zhang P; Liu Y; Fu C; Wang C; Duan X; Zou W; Zhao T
    Med Mol Morphol; 2019 Jun; 52(2):114-122. PubMed ID: 30564876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo.
    Li Y; Li L; Wu Z; Wang L; Wu Y; Li D; Ma U; Shao J; Yu H; Wang D
    Oncol Rep; 2017 Jul; 38(1):325-335. PubMed ID: 28560406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor suppresses glioma progression by upregulation of long non-coding RNA-p21.
    Yang J; Gan X; Tan B; Wang J; Chen Y
    Life Sci; 2019 Jan; 216():92-100. PubMed ID: 29981322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3β/β-catenin pathway.
    Zuo Z; Ji S; He L; Zhang Y; Peng Z; Han J
    Cell Biol Int; 2020 Nov; 44(11):2284-2292. PubMed ID: 32749739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
    Yu M; Xue Y; Zheng J; Liu X; Yu H; Liu L; Li Z; Liu Y
    Mol Cancer; 2017 Jun; 16(1):110. PubMed ID: 28651608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.